CDMO Overview

/CDMO Overview
CDMO Overview 2018-06-05T14:01:06+00:00

Providing Access to Best-in-Class,
Rapid mAb Development and Manufacturing

CDMO Process Development Lab
Stelis Biopharma And Oncobiologics Unveil Bio2Source CDMO Offering at BIO 2018

Oncobiologics utilizes our BioSymphony platform to provide contract development and manufacturing services to development stage biotech and biopharmaceutical partners from our 66,000 sq. ft. biologics development and manufacturing facility in Cranbury, New Jersey.

Our seasoned team of industry specialists offers partners immediate access to best-in-class infrastructure, equipment and expertise across scientific, manufacturing, regulatory and clinical functions.

  • By design, our teams operate under one roof in an integrated facility, enabling collaborative iteration and consistency that speeds programs and ensures robust end results.

  • Our BioSymphony platform seamlessly unites development, manufacturing, regulatory and clinical expertise to reduce both time and cost.

  • This model has been proven with our own portfolio of biosimilar assets, including multiple products that have successfully advanced into the clinic.

Stelis Biopharma And Oncobiologics Unveil Bio2Source CDMO Offering At BIO 2018


BioSymphony mAb Platform


By leveraging our proprietary BioSymphony™ Platform, Oncobiologics is able to produce high-quality mAb candidates in an efficient and cost-effective manner.

CDMO Capabilities

cGMP Manufacturing
Process Development
Cell & Molecular Biology
Analytics & Formulations Development
Regulatory & Clinical Development
Program Management